Jefferies 2019 Global Healthcare Conference

AGENDA

JUNE 4-7, 2019

Grand Hyatt New York, NY

Jefferies 2019 Global Healthcare Conference

You are invited to attend the Jefferies 2019 Global Healthcare Conference taking place June 4-7 at the Grand Hyatt in New York City.

Following the success of our 2018 conference, with over 400 participating companies and 2,700 attendees, we will again feature an extensive range of public & private healthcare companies across the Biopharmaceuticals, Life Sciences, Healthcare Services, Healthcare IT and Medical Technology sectors. This global gathering of leading executives, institutional investors, private equity investors and VCs will address near- and long-term investment opportunities and discuss the mechanisms driving healthcare in the U.S. and internationally.

The four-day conference will be comprised of company presentations, Q&A breakout sessions, keynotes & thematic panels. Company management teams and investors will also have the opportunity to participate in 1x1 and small group meetings.

To add this conference to your Microsoft Outlook calendar, click here.

REGISTRATION: Please contact your Jefferies representative

PARTICIPATING COMPANIES: 060419

HOTEL INFORMATION: Jefferies has reserved a block of rooms at the Grand Hyatt New York (109 E. 42nd Street at Grand Central Terminal) at a negotiated rate of $445 per night (plus tax). Rooms are based on availability and reservations must be made by Monday, May 13 in order to guarantee the conference rate. Please note that rooms must be cancelled by 3pm EST at least 72 hours prior to arrival. To make a reservation, please click here. For any questions, you can call the hotel directly at 1-800-233-1234.

QUESTIONS: healthcareconference@

? 2019 Jefferies LLC. Member SIPC.

AGENDA TUESDAY, JUNE 4, 2019

Jefferies 2019 Global Healthcare Conference

7:30 AM 8:00 AM 8:30 AM

9:00 AM 9:30 AM 10:00 AM 10:30 AM 11:00 AM

11:30 AM

BALLROOM 1 BREAKOUT: URIS

Breakfast & Registration

BALLROOM 2 BREAKOUT: JUILLIARD

BALLROOM 3 BREAKOUT: BROADWAY

BALLROOM 4 BREAKOUT: CARNEGIE

BALLROOM 5 BREAKOUT: ALVIN

MOROSCO BREAKOUT: PLYMOUTH

IMPERIAL BREAKOUT: BOOTH

Albireo Pharma, Inc. (ALBO) Biotechnology Ron Cooper, President & CEO

Ultragenyx Pharmaceutical Inc. (RARE) FC Biotechnology Shalini Sharp, CFO

Sartorius AG (SARTF)** MedTech Rainer Lehmann, CFO; Ben Orzelek, Head of IR

Twist Bioscience Corporation Menlo Therapeutics Inc.

(TWST)

(MNLO)

Life Sciences

Biotechnology

Emily Leproust, CEO

Steve Basta, CEO

ImmunityBio, Inc. (Private) Telix Pharmaceuticals Limited

Biotechnology

TLX AU)

Patrick Soon-Shiong, Chairman Pharmaceuticals

& CEO

Christian Behrenbruch, CEO

Quotient Limited (QTNT) MedTech Chris Lindop, CFO

Swedish Orphan Biovitrum AB (SOBI SS) Biotechnology Henrik Stenqvist; CFO; Armin Reininger; Head of Medical & Scientific Affairs

QIAGEN N.V. (QGEN)** FC Life Sciences Peer Schatz, CEO

Medpace Holdings, Inc. (MEDP)** FC Healthcare Services August Troendle, President & CEO; Jesse Geiger, CFO & COO, Laboratory Operations

Heska Corporation (HSKA)** NantKwest, Inc. (NK)

Pandion Therapeutics, Inc.

Animal Health

Biotechnology

(Private)

Kevin Wilson, CEO & President Patrick Soon-Shiong, Chairman Biotechnology

& CEO

Anthony Coyle, President &

CEO

Surgery Partners, Inc. (SGRY) NovoCure Limited (NVCR)

FC

MedTech

Healthcare Services

Bill Doyle, Executive Chairman

Tom Cowhey, CFO

Lonza Group Ltd (LONN VX) Biotechnology Rodolfo Savitzky, CFO

Urogen Pharma Ltd. (URGN) Biotechnology Liz Barrett, CEO

miRagen Therapeutics, Inc. (MGEN) Biotechnology William Marshall, President & CEO

Lyra Therapeutics (Private)** Arcutis, Inc. (Private)

Biotechnology

Pharmaceuticals

Maria Palasis, President & CEO Frank Watanabe, President &

CEO

Knight Therapeutics Inc. (04K GR) Pharmaceuticals Jonathan Goodman, CEO

Allogene Therapeutics, Inc. (ALLO) Biotechnology Eric Schmidt, CFO

Cerner Corporation (CERN) HCIT Marc Naughton, EVP & CFO

Mithra Women's Health (MITRA BB) Pharmaceuticals Alexandra Deschner, IR Officer

Eagle Pharmaceuticals, Inc. (EGRX) Pharmaceuticals Scott Tarriff, CEO; Pete Meyers, CFO

Scholar Rock, Inc. (SRRK) Pharmaceuticals Nagesh Mahanthappa, President & CEO

Intuity Medical, Inc. (Private) MedTech Emory Anderson, President & CEO

Addus HomeCare Corporation (ADUS) FC Healthcare Services Dirk Allison, President & CEO; Brian Poff, EVP & CFO

PRA Health Sciences, Inc. (PRAH)** FC Healthcare Services Colin Shannon, CEO; Mike Bonello, CFO

Bio-Rad Laboratories (BIO) Life Sciences Norman Schwartz, President; Ilan Daskal, CFO

Pacira BioSciences, Inc. (PCRX)** Pharmaceuticals Dave Stack, CEO

Translate Bio, Inc. (TBIO) Biotechnology Ronald Renaud, CEO

Nordic Nanovector ASA (NANO NO) Biotechnology Eduardo Bravo, CEO

Cadent Therapeutics (Private) Pharmaceuticals Jodie Morrison, CEO

Viking Therapeutics, Inc. (VKTX) Biotechnology

Brian Lian, President & CEO

Teladoc Health (TDOC) Healthcare Services Jason Gorevic, CEO; Valerie Haertel, IR

H. Lundbeck A/S (LUN DC) Pharmaceuticals Peter Anastasiou, EVP, Lundbeck North America

Retrophin, Inc. (RTRX)** FC Biotechnology Eric Dube, CEO

Surmodics, Inc. (SRDX) MedTech Gary Maharaj, President & CEO; Tim Arens, VP of Finance & CFO

CytomX Therapeutics, Inc. Indivior PLC (INDV LN)

(CTMX)

Pharmaceuticals

Biotechnology

Shaun Thaxter, CEO

Sean McCarthy, President, CEO

& Chairman

Vanda Pharmaceuticals Inc. LivaNova PLC (LIVN) FC

(VNDA)

MedTech

Biotechnology

Damien McDonald, CEO

Mihales Polymeropoulos, M.D.,

President & CEO; Jim Kelly,

EVP, CFO & Treasurer

Humana Inc. (HUM) FC Healthcare Services Bruce Broussard, President & CEO; Brian Kane, CFO

Acadia Healthcare Company, Inc. (ACHC)** FC Healthcare Services Debbie Osteen, CEO; David Duckworth, CFO

OptiNose, Inc. (OPTN) Pharmaceuticals Peter Miller, CEO

Dova Pharmaceuticals, Inc. (DOVA) Pharmaceuticals David Zaccardelli, CEO

KSQ Therapeutics, Inc. (Private) Biotechnology David P. Meeker Meeker, CEO

CRISPR Therapeutics AG (CRSP) Biotechnology Sam Kulkarni, CEO

bluebird bio, Inc. (BLUE) Biotechnology Chip Baird, CFO

Roche Holding AG (ROG VX) Pharmaceuticals Alan Hippe, CFO Roche

HMS Holdings Corp. (HMSY)** Healthcare Services Jeff Sherman, EVP & CFO

Establishment Labs Holdings Urovant Sciences Ltd. (UROV) Grace Therapeutics Inc.

Inc. (ESTA)

Pharmaceuticals

(Private)

MedTech

Keith Katkin, President & CEO; Biotechnology

Juan Jose Chacon Quiros, CEO; Cornelia Haag-Molkenteller, George Kottayil, CEO; Bruce

Renee Gaeta, CFO

CMO; Michael McFadden,

Hochstadt, COO

Chief Commercial Officer; Paul

Mudd, VP, Clinical Research

** No Breakout FC Fireside Chat

AGENDA TUESDAY, JUNE 4, 2019

Jefferies 2019 Global Healthcare Conference

12:00 PM 12:15 PM

BALLROOM 1 BREAKOUT: URIS

BALLROOM 2 BREAKOUT: JUILLIARD

Break for Lunch / Presentation Room Setup

BALLROOM 3 BREAKOUT: BROADWAY

BALLROOM 4 BREAKOUT: CARNEGIE

BALLROOM 5 BREAKOUT: ALVIN

"Drug Pricing: The Politics and Outlook" Ted Kennedy, Jr., Partner, Epstein Becker Green & Lynn Shapiro Snyder, Senior Member, Epstein Becker Green

MOROSCO BREAKOUT: PLYMOUTH

IMPERIAL BREAKOUT: BOOTH

1:30 PM 2:00 PM 2:30 PM 3:00 PM 3:30 PM 4:00 PM 4:30 PM

Fluidigm Corporation (FLDM) Life Sciences Vikram Jog, CFO

United Therapeutics Corporation (UTHR) Biotechnology James Edgemond, CFO & Treasurer

Novartis AG (NOVN VX)** FC Amedisys, Inc. (AMED) FC

Pharmaceuticals

Healthcare Services

Fabrice Chouraqui, US

Paul Kusserow, CEO

President

Xeris Pharmaceuticals, Inc. (XERS)** Pharmaceuticals Paul Edick, CEO

IGM Biosciences, Inc. (Private) Biotechnology Fred M. Schwarzer, CEO

BioScrip, Inc. (BIOS) Healthcare Services Dan Greenleaf, President & CEO; Steve Deitsch, SVP, CFO & Treasurer

NextGen Healthcare, Inc. (NXGN) HCIT Rusty Frantz, President & CEO

The Cooper Companies, Inc. (COO) FC MedTech Brian Andrews, SVP, CFO & Treasurer

Veloxis Pharmaceuticals A/S (VELO DC) Pharmaceuticals Craig Collard, CEO

Bellicum Pharmaceuticals, Inc. (BLCM)** Biotechnology Rick Fair, President & CEO

Veru Inc. (VERU) Pharmaceuticals Mitchell Steiner, Chairman, President CEO

Aura Biosciences, Inc. (Private) Biotechnology Elisabet de los Pinos, CEO

Ra Pharmaceuticals, Inc. (RARX) Biotechnology Doug Treco, President & CEO

MEDNAX, Inc. (MD) FC Healthcare Services Stephen Farber, CFO; Charles Lynch, VP, Strategy

Mettler-Toledo International Inc. (MTD) FC Life Sciences Shawn Vadala, CFO

Aerie Pharmaceuticals, Inc. (AERI)** Pharmaceuticals

Vince Anido, Chairman & CEO

Corbus Pharmaceuticals Holdings, Inc. (CRBP) Pharmaceuticals Yuval Cohen, CEO

Collegium Pharmaceutical, Inc. (COLL) Pharmaceuticals Joe Ciaffoni, CEO; Paul Brannelly, EVP & CFO

Catalyst Biosciences, Inc. (CBIO) Biotechnology Nassim Usman, President & CEO; Fletcher Payne, CFO; Howard Levy, CMO

BioArctic AB (BIOAB LN) Biotechnology Gunilla Osswald, CEO; Johanna F?lting, VP, Translational Science & Pharmacology

West Pharmaceutical Services, Inc. (WST)** FC MedTech Eric Green, CEO & President

Hologic Inc. (HOLX) MedTech Karleen Oberton, CFO; Michael Watts, VP, IR & Corp Communications

Vocera Communications, Inc. Akebia Therapeutics, Inc.

(VCRA) FC

(AKBA)**

HCIT

Biotechnology

Brent Lang, CEO; Sue Dooley, John Butler, CEO

Head of IR

Verrica Pharmaceuticals Inc. (VRCA) Pharmaceuticals Ted White, President & CEO

Minerva Neurosciences, Inc. (NERV) Biotechnology Remy Luthringer, Executive Chairman & CEO

Corcept Therapeutics Incorporated (CORT) Pharmaceuticals Joseph Belanoff, CEO

Galapagos NV (GLPG NA) Biotechnology Onno van de Stolpe, CEO

Exact Sciences Corporation (EXAS) FC Life Sciences Kevin Conroy, President & CEO

Apellis Pharmaceuticals, Inc. (APLS) Biotechnology Cedric Francois, CEO

Banca Farmafactoring S.p.a. (BFF IM) Healthcare Services Massimiliano Belingheri, CEO; Emanuele Bona, CFO; Enrico Tadiotto, Head of IR, Strategy, M&A

PDL BioPharma, Inc. (PDLI) Pharmaceuticals Dominique Monnet, President & CEO; Peter Garcia, CFO

EUSA Pharma Ltd (Private) Pharmaceuticals Lee Morley, CEO

Arcus Biosciences, Inc. (RCUS)** Biotechnology Terry Rosen, CEO; Katherine Bock, VP, IR & Corp Strategy

Luminex Corporation

Aurora Cannabis Inc.

(LMNX) FC

(ACB)

Life Sciences

Cannabis

Homi Shamir, President & CEO Cam Battley, Chief Corporate

Officer

Dicerna Pharmaceuticals, Inc. (DRNA) Biotechnology Doug Fambrough, CEO

BioDelivery Sciences International, Inc. (BDSI) Pharmaceuticals Herm Cukier, CEO

Kiadis Pharma N.V. (KDS NA)** Biotechnology Arthur Lahr, CEO

Metacrine, Inc. (Private)** Biotechnology Ken Song, CEO

Orasure Technologies, Inc. (OSUR) FC Life Sciences Stephen Tang, President & CEO; Roberto Cuca, CFO

HEXO Corp. (HEXO B3) Cannabis Sebastien St-Louis, CEO & Co-Founder

Abiomed Inc (ABMD) MedTech Michael Minogue, CEO; Todd Trapp, CFO

R1 RCM Inc. (RCM)** FC

Camurus (CAMX SS)**

Healthcare Services

Pharmaceuticals

Joe Flanagan, President & CEO; Fredrik Tiberg, President &

Chris Ricaurte, CFO &

CEO

Treasurer

Marker Therapeutics, Inc. (MRKR) Biotechnology Peter Hoang, President & CEO

Compugen Ltd. (CGEN)** Biotechnology Anat Cohen-Dayag, President & CEO

** No Breakout FC Fireside Chat

AGENDA WEDNESDAY, JUNE 5, 2019

Jefferies 2019 Global Healthcare Conference

7:30 AM 8:00 AM

8:30 AM 9:00 AM 9:30 AM

10:00 AM

10:30 AM 11:00 AM 11:30 AM

BALLROOM 1 BREAKOUT: URIS

Breakfast & Registration

BALLROOM 2 BREAKOUT: JUILLIARD

BALLROOM 3 BREAKOUT: BROADWAY

BALLROOM 4 BREAKOUT: CARNEGIE

BALLROOM 5 BREAKOUT: ALVIN

MOROSCO BREAKOUT: PLYMOUTH

IMPERIAL BREAKOUT: BOOTH

Acorda Therapeutics, Inc. (ACOR)** FC Biotechnology Ron Cohen, M.D., President & CEO

MorphoSys AG (MOR GR) Biotechnology Jens Holstein, CFO

Alcon, Inc. (ALC)** FC Healthcare Services David Endicott, CEO; Tim Stonesifer, CFO; Christina Cheng, Global Head, IR

Intra-Cellular Therapies, Inc. (ITCI)** Biotechnology Sharon Mates, CEO

Castlight Health, Inc. (CSLT) HCIT Siobhan Nolan Mangini, CFO

Sierra Oncology, Inc. (SRRA Biotechnology Dr. Nick Glover, President & CEO

Aileron Therapeutics, Inc. (ALRN) Biotechnology Manuel Aivado, President & CEO; Donald Dougherty, SVP & CFO

Amphastar Pharmaceuticals, Inc. (AMPH) Pharmaceuticals Jason Shandell, President; Bill Peters, CFO

Esperion (ESPR) FC Pharmaceuticals Jason Shandell, President; Tim Mayleben, President & CEO

Charles River Laboratories International, Inc. (CRL) FC Healthcare Services David Smith, EVP & CFO

Atara Biotherapeutics, Inc. (ATRA) Biotechnology Utpal Koppikar, CFO

Genfit SA (GNFT) Life Sciences Dean Hum, COO

Aeglea BioTherapeutics, Inc. (AGLE) Biotechnology Anthony Quinn, CEO

Verona Pharma plc (VRNA) Biotechnology Jan-Anders Karlsson, CEO; Piers Morgan, CFO

TG Therapeutics, Inc. (TGTX) Brooks Automation, Inc.

Biotechnology

(BRKS)

Michael Weiss, CEO

Life Sciences

Lindon Robertson, EVP & CFO

Array BioPharma Inc. (ARRY)** FC Biotechnology Ron Squarer, CEO

CareDx, Inc (CDNA) Biotechnology Peter Maag, CEO

Synthorx, Inc. (THOR) Biotechnology Marcos Milla, Chief Scientific Officer

Assembly Biosciences, Inc. (ASMB)** Biotechnology Derek Small, President & CEO

Enzyvant (Private) Pharmaceuticals Rachelle Jacques, CEO

Cara Therapeutics, Inc. (CARA) Biotechnology Derek Chalmers, CEO

Bio-Techne Corporation (TECH) Life Sciences Chuck Kummeth, CEO

ICON Plc (ICLR) FC Healthcare Services Steve Cutler, CEO

U.S. Physical Therapy, Inc. (USPH) FC Healthcare Services Christopher Reading, CEO

Kezar Life Sciences, Inc.

Oncorus, Inc. (Private)

(KZR) FC

Biotechnology

Biotechnology

Ted Ashburn, CEO

John Fowler, CEO; Christopher

Kirk, President & CSO; Niti

Goel, CMO

Beam Therapeutics Inc. (Private) Biotechnology John Evans, CEO

Rubius Therapeutics, Inc. (RUBY) Biotechnology Pablo Cagnoni, CEO

BioCryst Pharmaceuticals, Inc. (BCRX) FC Biotechnology Jon Stonehouse, CEO

OSI Systems, Inc. (OSIS) MedTech Alan Edrick, EVP & CFO

Syneos Health, Inc. (SYNH) Healthcare Services Alistair Macdonald, CEO

Trends in Healthcare Private Equity Panel Moderator: Michael Dodds Panelists: Andrew Kaplan, Bain Robert Reistetter, Quad-C John Richardson, Cinven TJ Rose, ABRY

Coherus Biosciences, Inc. (CHRS)** FC Biotechnology Denny Lanfear, President & CEO

Cosmo Pharmaceuticals N.V. (COPN SW) Pharmaceuticals Alessandro Della Cha, CEO

Kiniksa Pharmaceuticals, Ltd. Affimed N.V. (AFMD)

(KNSA)

Biotechnology

Biotechnology

Adi Hoess, CEO

Sanj K. Patel, CEO & Chairman

of the Board; John Paolini,

CMO

Equillium, Inc. (EQ) Biotechnology Daniel Bradbury, Chairman & CEO

TCR2 Therapeutics Inc. (TCRR) Biotechnology Ian Somaiya, CFO

Concert Pharmaceuticals, Inc. Poxel SA (POXEL FP)

(CNCE)

Biotechnology

Biotechnology

Thomas Kuhn, CEO

Roger Tung, President & CEO

Constellation Pharmaceuticals, Inc. (CNST) Biotechnology Jigar Raythatha, CEO

Chemed Corporation (CHE)** FC Healthcare Services Kevin McNamara, President & CEO

Medtronic plc (MDT) FC MedTech Mike Coyle, EVP & President, Cardiac & Vascular Group

Replimune Group, Inc. (REPL) Biotechnology Philip Astley-Sparkle, Executive Chairman & Director

Iovance Biotherapeutics, Inc. (IOVA) Biotechnology Maria Fardis, President & CEO; Timothy Morris, CFO

Gilead Sciences, Inc. (GILD)** FC Biotechnology Daniel O'Day, Chairman & CEO

Immunomedics, Inc. (IMMU)** FC Biotechnology Behzad Aghazadeh, Executive Chairman

Xenon Pharmaceuticals Inc. (XENE)** Biotechnology Simon Pimstone, CEO

PureTech Health plc (PRTC Kadmon Holdings, Inc.

LN)

(KDMN)**

Biotechnology

Biotechnology

Daphne Zohar, Founder & CEO Harlan Waksal, President &

CEO

Corvus Pharmaceuticals, Inc. BlueRock Therapeutics

(CRVS)

(Private)

Biotechnology

Biotechnology

Richard Miller, President & CEO Emile Nuwaysir, CEO

Orexo AB (ORX SS) Pharmaceuticals Joseph DeFeo, EVP & CFO; Robert DeLuca, President Orexo US Inc

Intec Pharma Ltd. (NTEC)** Biotechnology Jeffrey Meckler, Vice Chairman & CEO

** No Breakout FC Fireside Chat

AGENDA WEDNESDAY, JUNE 5, 2019

Jefferies 2019 Global Healthcare Conference

12:00 PM 12:15 PM

1:00 PM 2:00 PM

2:30 PM

3:00 PM

3:30 PM

4:00 PM

4:30 PM

BALLROOM 1 BREAKOUT: URIS

BALLROOM 2 BREAKOUT: JUILLIARD

Break for Lunch / Presentation Room Setup

BALLROOM 3 BREAKOUT: BROADWAY

BALLROOM 4 BREAKOUT: CARNEGIE

BALLROOM 5 BREAKOUT: ALVIN

MOROSCO BREAKOUT: PLYMOUTH

IMPERIAL BREAKOUT: BOOTH

Craig B. Thompson, MD, President and CEO of Memorial Sloan Kettering Cancer Center ~ Michael Yee, Managing Director, Equity Research, Jefferies (12:15-12:45pm)

Michael R. Bloomberg, Founder, Bloomberg LP and Bloomberg Philanthropies & 108th Mayor of the City of New York ~ Moderated by Brian Friedman, President, Jefferies Financial Group (1:00-1:45pm)

WAVE Life Sciences Ltd. (WVE) Biotechnology Paul Bolno, President & CEO

Genomic Health, Inc. (GHDX) Reata Pharmaceuticals, Inc.

Life Sciences

(RETA) FC

Kim Popovits, CEO; Brad Cole, Biotechnology

CFO; Emily Faucette, VP, IR

Colin Meyer, Chief Medical

Officer; Vinny Jindal, VP,

Strategy

Supernus Pharmaceuticals, Inc. (SUPN) FC Pharmaceuticals Jack Khattar, CEO

Odonate Therapeutics, Inc. (ODT) Pharmaceuticals Kevin Tang, CEO

GlycoMimetics, Inc. (GLYC) Biotechnology Rachel King, CEO

Passage BIO, Inc. (Private)** Life Sciences Jill Quigley, COO & General Counsel

Rigel Pharmaceuticals, Inc.)** Biotechnology Dean Schorno, CFO

UDG Healthcare plc (UDG LN) Healthcare Services Liam Logue, Head of Corp Development

Align Technology Inc. (ALGN) MedTech John Morici, CFO

Autolus Therapeutics plc (AUTL)** FC Biotechnology Christian Itin, CEO

Abeona Therapeutics Inc. (ABEO) Biotechnology Jo?o Siffert, CEO, CMO & Head of R&D

Seres Therapeutics, Inc. (MCRB) Biotechnology Eric Shaff, President & CEO

Yumanity Therapeutics Inc. (Private) Biotechnology Tony Coles, CEO

Stealth BioTherapeutics Incorporated (MITO) Pharmaceuticals Reenie McCarthy, CEO

Epizyme, Inc. (EPZM) Biotechnology Robert Bazemore, President & CEO

Heron Therapeutics, Inc. (HRTX) Biotechnology Barry Quart, President & CEO

AxoGen, Inc. (AXGN) MedTech Karen Zaderej, Chairman, President & CEO

Karyopharm Therapeutics Inc. (KPTI) Biotechnology Michael Kauffman, CEO

AMAG Pharmaceuticals, Inc. (AMAG) Pharmaceuticals Bill Heiden, CEO

Arbutus Biopharma Corporation (ABUS) Biotechnology Michael McElhaugh, Chief Business Officer

Cassiopea S.p.A. (SKIN SW) Pharmaceuticals Diana Harbort, CEO

Orion Corporation (ORNBV FH) Pharmaceuticals Jari Karlson, CFO

Canopy Growth Corporation Spectrum Pharmaceuticals,

(CGC)

Inc. (SPPI)

Cannabis

Biotechnology

Bruce Linton, Chairman & CEO Joe Turgeon, CEO & President

Aclaris Therapeutics, Inc. (ACRS) Biotechnology Neal Walker, President & CEO; Stuart Shanler, CSO; Mike Tung, SVP, IR

BELLUS Health Inc. (BLU CN) Biotechnology Roberto Bellini, President & CEO

EyePoint Pharmaceuticals, Inc. (EYPT) Biotechnology Nancy Lurker, President & CEO

Allscripts Healthcare Solutions, Inc. (MDRX)** HCIT Dennis Olis, CFO

Blueprint Medicines Corporation (BPMC) Biotechnology Kate Haviland, COO

LHC Group, Inc. (LHCG) FC Zai Lab Limited (ZLAB)

Healthcare Services

Biotechnology

Keith Myers, Chairman & CEO; Tao Fu, President & COO

Josh Proffitt, CFO; Bruce

Greenstein, Chief Strategy

Officer

Tabula Rasa HealthCare, Inc. (TRHC) Healthcare Services Brian Adams, CFO

Hanger, Inc. (HNGR) Healthcare Services Thomas Kiraly, CFO; Seth Frank, VP, Treasury & IR

ALX Oncology (Private) Biotechnology Jaume Pons, CEO

Evolus, Inc. (EOLS)** Pharmaceuticals David Moatazedi, President & CEO; Lauren Silvernail, CFO & EVP, Corp Development

Healthcare Services Group, Inc. (HCSG) Healthcare Services Ted Wahl, President & CEO; Matt McKee, Chief Communications Officer

Integra LifeSciences Holdings Brookdale Senior Living Inc.

Corporation (IART)** FC

(BKD) FC

MedTech

Healthcare Services

Peter Arduini, President & CEO Cindy Baier, CEO

Cytosorbents Corporation (CTSO) MedTech Phillip Chan, CEO & President

CTI BioPharma Corp. (CTIC) Biotechnology Bruce Seeley, COO

Cardiva Medical, Inc. (Private) MedTech John Russell, CEO

** No Breakout FC Fireside Chat

 ................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download